Accordingly, infusion of [Pyr1]apelin-13 1 nmol/min did not have demonstrable hemodynamic effects in either healthy subjects or patients with CKD (Supplementary Figs. 2–4). This evidence concerns the gene APLN and chronic kidney disease.